[Effects of angiotensin II analogue on rabbits with acute and chronic two-kidney, one clip hypertension (author's transl)]. 1979

S Yamasaki, and H Nakatani, and K Kusunoki, and T Kawashima, and H Kawamura, and T Ohara, and H Shintani, and N Taniguchi, and T Nagai

UI MeSH Term Description Entries
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D006978 Hypertension, Renovascular Hypertension due to RENAL ARTERY OBSTRUCTION or compression. Hypertension, Goldblatt,Goldblatt Syndrome,Goldblatt Hypertension,Renovascular Hypertension,Syndrome, Goldblatt
D008297 Male Males
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012504 Saralasin An octapeptide analog of angiotensin II (bovine) with amino acids 1 and 8 replaced with sarcosine and alanine, respectively. It is a highly specific competitive inhibitor of angiotensin II that is used in the diagnosis of HYPERTENSION. 1-Sar-8-Ala Angiotensin II,1-Sarcosine-8-Alanine Angiotensin II,(Sar(1),Ala(8))ANGII,(Sar1,Val5,Ala8)Angiotensin II,Angiotensin II, Sar(1)-Ala(8)-,Angiotensin II, Sarcosyl(1)-Alanine(8)-,Sar-Arg-Val-Tyr-Val-His-Pro-Ala,Saralasin Acetate,Saralasin Acetate, Anhydrous,Saralasin Acetate, Hydrated,1 Sar 8 Ala Angiotensin II,1 Sarcosine 8 Alanine Angiotensin II,Angiotensin II, 1-Sar-8-Ala,Angiotensin II, 1-Sarcosine-8-Alanine,Anhydrous Saralasin Acetate,Hydrated Saralasin Acetate
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

S Yamasaki, and H Nakatani, and K Kusunoki, and T Kawashima, and H Kawamura, and T Ohara, and H Shintani, and N Taniguchi, and T Nagai
September 1991, Nihon Jinzo Gakkai shi,
S Yamasaki, and H Nakatani, and K Kusunoki, and T Kawashima, and H Kawamura, and T Ohara, and H Shintani, and N Taniguchi, and T Nagai
June 1992, Hypertension (Dallas, Tex. : 1979),
S Yamasaki, and H Nakatani, and K Kusunoki, and T Kawashima, and H Kawamura, and T Ohara, and H Shintani, and N Taniguchi, and T Nagai
April 1997, Hypertension (Dallas, Tex. : 1979),
S Yamasaki, and H Nakatani, and K Kusunoki, and T Kawashima, and H Kawamura, and T Ohara, and H Shintani, and N Taniguchi, and T Nagai
July 1987, Atherosclerosis,
S Yamasaki, and H Nakatani, and K Kusunoki, and T Kawashima, and H Kawamura, and T Ohara, and H Shintani, and N Taniguchi, and T Nagai
July 1988, Journal of hypertension,
S Yamasaki, and H Nakatani, and K Kusunoki, and T Kawashima, and H Kawamura, and T Ohara, and H Shintani, and N Taniguchi, and T Nagai
September 1989, Hypertension (Dallas, Tex. : 1979),
S Yamasaki, and H Nakatani, and K Kusunoki, and T Kawashima, and H Kawamura, and T Ohara, and H Shintani, and N Taniguchi, and T Nagai
December 1978, Masui. The Japanese journal of anesthesiology,
S Yamasaki, and H Nakatani, and K Kusunoki, and T Kawashima, and H Kawamura, and T Ohara, and H Shintani, and N Taniguchi, and T Nagai
April 1987, Journal of hypertension,
S Yamasaki, and H Nakatani, and K Kusunoki, and T Kawashima, and H Kawamura, and T Ohara, and H Shintani, and N Taniguchi, and T Nagai
July 2006, American journal of physiology. Renal physiology,
S Yamasaki, and H Nakatani, and K Kusunoki, and T Kawashima, and H Kawamura, and T Ohara, and H Shintani, and N Taniguchi, and T Nagai
January 1997, Clinical and experimental hypertension (New York, N.Y. : 1993),
Copied contents to your clipboard!